The Growth Rate of the Pharmaceutical Industry is Expected to Increase to 12.5% in 2018
In 2018, with the advent of related policy dividends in recent years and the increase of cross industry capital investment, the production of the pharmaceutical industry will continue to grow at high speed.
In recent years, the Central Committee of the Communist Party of China, the State Council and the management departments of related industries have issued a number of related documents in the field of medicine, including Made in China 2025, Healthy China 2030, reforming the management of clinical trials, expediting the review and approval of the listing, promoting the innovation of drugs and the development of generic drugs, strengthening the whole life cycle management of medical equipment, upgrading the technical support capability and strengthening the organization and implementation. On the one hand, the introduction of these good policies will directly drive the development of the industry. On the other hand, it will lead to the influx of capital into the pharmaceutical industry and the increase of investment, the relative pharmaceutical machinery industry as well. It is expected that the growth rate of the pharmaceutical industry will continue to maintain double digits and increase to about 12.5% in 2018.